Times are shown in your local time zone GMT
Ad-blocker Detected - Your browser has an ad-blocker enabled, please disable it to ensure your attendance is not impacted, such as CPD tracking (if relevant). For technical help, contact Support.
Vimal SACHDEVA
Technical officer (Senior GMP Inspector) - World Health Organization
Featured
Professional Bio
Mr Vimal Sachdeva holds a Master’s Degree in Chemistry as well as a Post Graduate Diploma
in Pharmaceutical Technology and Business Management.
He has more than 30 years of pharmaceutical industry experience including 15 years as a
regulator of health products. Before joining WHO, Mr Sachdeva worked with the Singapore
Health Sciences Authority (HSA) as a Senior GMP Auditor and Regulatory Consultant, and a
member of the Quality Control Advisory Committee (QCAC) appointed by the Minister for
Health of the Republic of Singapore.
Upon leaving Singapore HSA, Mr Vimal Sachdeva has been working as a Senior Inspector with
the WHO PQT (for medicines, vaccines, IVDs and diagnostics) since 2010, in Geneva,
Switzerland. Under WHO PQT, Mr Sachdeva has been the Lead Inspector for many audits of
facilities manufacturing Active Pharmaceutical Ingredients (APIs) and Finished
Pharmaceutical Products (FPPs), Vaccines, Contract Research Organizations (CROs) and
National Pharmaceutical Quality Control Laboratories. To date, he has performed more than
200 inspections in Asia, Africa, Latin America, and North America.
Mr Sachdeva is a highly sought-after speaker and he has been frequently invited to present
papers in the field of GMP, GCP and GLP at various international conferences in Singapore,
India, China, Switzerland, Denmark, South Africa, Iran, Zimbabwe, Ethiopia, Namibia, Japan
and Indonesia. He also co-authored papers on GMP and supply chain integrity of active
pharmaceutical ingredients (APIs) and pharmaceutical excipients published in ISPE
Pharmaceutical Engineering in 2014. In 2017, one of the papers which Mr Sachdeva co-
authored, was awarded the ISPE Roger Sherwood Article of the Year.
In addition to speaking at international conferences and contributing papers and articles to
international scientific journals, Mr Sachdeva has also conducted several trainings and
workshops in various parts of the world. Recently, he was invited by the Generics and
Biosimilar Initiative (GaBI) based in Brussels as a Workshop Co-Chair, in addition to his role as
a speaker-cum-moderator for the 2nd ASEAN Education Workshop on GMP Inspection for
Biologicals/Biosimilars held in Jakarta, Indonesia. Mr Sachdeva was invited by the Duke-
National University of Singapore (NUS) as a faculty for the Graduate Certificate in
Pharmaceutical Regulations organised by the Duke-NUS Centre of Regulatory Excellence
(CoRE) in Singapore on Health Products including Biologics.
in Pharmaceutical Technology and Business Management.
He has more than 30 years of pharmaceutical industry experience including 15 years as a
regulator of health products. Before joining WHO, Mr Sachdeva worked with the Singapore
Health Sciences Authority (HSA) as a Senior GMP Auditor and Regulatory Consultant, and a
member of the Quality Control Advisory Committee (QCAC) appointed by the Minister for
Health of the Republic of Singapore.
Upon leaving Singapore HSA, Mr Vimal Sachdeva has been working as a Senior Inspector with
the WHO PQT (for medicines, vaccines, IVDs and diagnostics) since 2010, in Geneva,
Switzerland. Under WHO PQT, Mr Sachdeva has been the Lead Inspector for many audits of
facilities manufacturing Active Pharmaceutical Ingredients (APIs) and Finished
Pharmaceutical Products (FPPs), Vaccines, Contract Research Organizations (CROs) and
National Pharmaceutical Quality Control Laboratories. To date, he has performed more than
200 inspections in Asia, Africa, Latin America, and North America.
Mr Sachdeva is a highly sought-after speaker and he has been frequently invited to present
papers in the field of GMP, GCP and GLP at various international conferences in Singapore,
India, China, Switzerland, Denmark, South Africa, Iran, Zimbabwe, Ethiopia, Namibia, Japan
and Indonesia. He also co-authored papers on GMP and supply chain integrity of active
pharmaceutical ingredients (APIs) and pharmaceutical excipients published in ISPE
Pharmaceutical Engineering in 2014. In 2017, one of the papers which Mr Sachdeva co-
authored, was awarded the ISPE Roger Sherwood Article of the Year.
In addition to speaking at international conferences and contributing papers and articles to
international scientific journals, Mr Sachdeva has also conducted several trainings and
workshops in various parts of the world. Recently, he was invited by the Generics and
Biosimilar Initiative (GaBI) based in Brussels as a Workshop Co-Chair, in addition to his role as
a speaker-cum-moderator for the 2nd ASEAN Education Workshop on GMP Inspection for
Biologicals/Biosimilars held in Jakarta, Indonesia. Mr Sachdeva was invited by the Duke-
National University of Singapore (NUS) as a faculty for the Graduate Certificate in
Pharmaceutical Regulations organised by the Duke-NUS Centre of Regulatory Excellence
(CoRE) in Singapore on Health Products including Biologics.